On Cancer: Clinical Trials

Share
Print
and/or
144 Blog posts found

Feature

On the Front Lines: Meet the Specialized Nurses Helping Move Cancer Research Forward

Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials.

Two nurses talking at a desk

In the Clinic

Targeted Drug Shows Promise Against HER2-Positive Breast Cancer That Stops Responding to Other Drugs

MSK medical oncologist Shanu Modi is the lead author of a new paper detailing the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. Results from this study were also presented at the San Antonio Breast Cancer Symposium.

Illustration of breast cancer cell

In the News

MSK Experts Report New Findings about Multiple Myeloma at the 2019 ASH Meeting

Two studies on multiple myeloma provide new information about diagnosing and treating this blood cancer.

Micrograph of multiple myeloma cells

In the News

MSK Experts Report Advances in Lymphoma Treatment at the 2019 ASH Meeting

Learn more about the work of MSK lymphoma researchers being presented at the 2019 meeting of the American Society of Hematology.

Exterior shot of building at ASH meeting

Finding

Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis

In an international study led by MSK, researchers reported finding key mutations driving the disease histiocytosis for nearly all of the people included.

Two images of a human torso show a reduction in tumors after treatment with targeted therapy.

In the Clinic

For MSK’s Gynecologic Oncologists, Uncommon Cancers Aren’t Always Rare

Learn about MSK’s expertise in treating vulvar and vaginal cancers, uterine sarcoma, uncommon ovarian cancers, and gestational trophoblastic disease.

Surgeon Mario Leitao in the operating room

Q&A

Meet Julia Glade Bender, Who’s Focused on Developing Better Treatments for Kids with Cancer

Pediatric oncologist Julia Glade Bender talks about the challenges of treating rare childhood cancers and how personalized medicine is leading to better therapies for tumors that are especially hard to treat.

Pediatric oncologist Julia Glade Bender

In the Clinic

FDA Approves Pexidartinib, a Targeted Therapy for a Tumor of the Joints

Pexidartinib is the first drug approved specifically to treat tenosynovial giant cell tumor.

Medical oncologist William Tap

In the Clinic

5 Reasons MSK Excels at Treating Gynecologic Cancers

Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.

Memorial Sloan Kettering surgeons Oliver Zivanovic, Kara Long Roche, Ginger Gardner, and Yukio Sonoda